You are here


Original articles

Fang X., Zeisel M.B., Wilpert J., Barth H., Gissler B., Thimme R., Kreutz C., Maiwald T., Timmer J., Kern W.V., Donauer J., Geyer M., Walz G., Depla E., Von Weizsacker F., Blum H.E., Baumert T.F. Host cell responses induced by hepatitis C virus binding. Hepatology, 2006, 43, 1326-1336.

Barth H., Schnober E.K., Zhang F., Linhardt R.J., Depla E., Boson B., Cosset F.L., Patel A., Blum H.E., Baumert T.F. Viral and cellular determinants of the hepatitis C virus envelope-heparan sulfate interaction. J. Virol., 2006, 80, 10579-90.

Neumann-Haefelin C., Mckiernan S., Ward S., Viazov S., Spangenberg H.C., Killinger T., Baumert T.F., Nazarova N., Sheridan I., Pybus O., Von Weizsacker F., Roggendorf M., Kelleher D., Klenerman P., Blum H.E., Thimme R. Dominant influence of an HLA-B27 restricted CD8+ T cell response in mediating HCV clearance and evolution. Hepatology, 2006, 43, 563-572.

Codran A., Royer C., Jaeck D., Bastien-Valle M., Baumert T.F., Kieny M.P., Pereira C.A., Martin J.P. Entry of hepatitis C virus pseudotypes into primary human hepatocytes by clathrin-dependent endocytosis. J. Gen. Virol., 2006, 87, 2583-2593.

Pivert A., Payan C., Morand P., Fafi-Kemer S., Deshayes J., Carrat F., Pol S., Cacoub P., Perronne C., Lunel F. Comparison of serum hepatitis C virus (HCV) RNA and core antigen levels in patients coinfected with human immunodeficiency virus and HCV and treated with interferon plus ribavirin. J. Clin. Microbiol., 2006, 44, 417-422.

Schvoerer E., Thumann C., Spohrer S., Soulier E., Royer C., Brignon N., Doridot S., Meyer N., Ellero B., Woehl-Jaegle M.L., Meyer C., Jaeck D., Wolf P., Stoll-Keller F. Early decrease in circulating dendritic cells number after liver transplantation could favour hepatitis C virus recurrence. J. Med. Virol., 2006, 78, 1070-1075.

Schvoerer E., Frechin V., Fritsch S., Freitag R., Fuchs A., Gut J.P., Stoll-Keller F. Atypical symptoms in patients with herpesvirus DNA detected by PCR in cerebrospinal fluid. J. Clin. Virol., 2006, 35, 458-462.

Choquet S., Leblond V., Herbrecht R., Socie G., Stoppa A.M., Vandenberghe P., Fischer A., Morschhauser F., Salles G., Feremans W., Vilmer E., Peraldi M.N., Lang P., Lebranchu Y., Oksenhendler E., Garnier J.L., Lamy T., Jaccard A., Ferrant A., Offner F., Hermine O., Moreau A., Fafi-Kremer S., Morand P., Chatenoud L., Berriot-Varoqueaux N., Bergougnoux L., Milpied N. Efficacy and safety of rituximab in B-cell post-transplantation lymphoproliferative disorders: results of a prospective multicenter phase 2 study. Blood, 2006, 107, 3053-7.

Zachary P., Wendling M.J., Djeddi S., Schvoerer E., Ullmann M., Stoll-Keller F., Gut J.P. Primary hepatitis C virus infection in an intravenous drug user: kinetics of virological markers. Gastroentérol. Clin. Biol., 2006, 30, 1419-20.

Lupberger J., Mund A., Kock J., Hildt E. Cultivation of HepG2.2.15 on Cytodex-3: higher yield of hepatitis B virus and less subviral particles compared to conventional culture methods. J. Hepatol., 2006, 45, 547-52.

Buerckstuemmer T., Kriegs M., Lupberger J., Pauli E.K., Schmittel S., Hildt E. Raf-1 kinase associates with hepatitis C virus NS5A and regulates viral replication. FEBS Lett., 2006, 580, 575-80.

Toussirot E., Robinet E., Saas P., Chabod J., Auge B., Cozma G., Tiberghien P., Roudier J., Wendling D. Bacterial extract (OM-89) specific and non specific immunomodulation in rheumatoid arthritis patients. Autoimmunity, 2006, 39, 299-306.

Zarski J.P., Marcellin P., Leroy V., Trepo C., Samuel D., Ganne-Carrie N., Barange K., Canva V., Doffoel M., Cales P. Fédération Nationale des Pôles de Référence et des Réseaux Hépatites. Characteristic of patients with chronic hepatitis B in France: predomina frequency of HBe antigen negative cases. J. Hepatol., 2006, 45, 355-60.

Fohrer C., Caillard S., Koumarianou A., Ellero B., Woehl-Jaegle M.L., Meyer C., Epailly E., Chenard M.P., Lioure B., Natarajan-Ame S., Maloisel F., Lutun P., Kessler R., Moulin B., Bergerat J.P., Wolf P., Herbrecht R. Long-term survival in post-transplant lymphoproliferative disorders with a dose-adjusted ACVBP regimen. Br. J. Haematol., 2006, 134, 602-12.

Kessler L., Lucescu C., Pinget M., Charton M.N., Mutschler V., Wolf P., Berney T., Benhamou P.Y., Gragil Group. Tacrolimus-associated optic neuropathy after pancreatic islet transplantation using a sirolimus/tacrolimus immunosuppressive regimen. Transplantation, 2006, 81, 636-7.

Barussaud M., Regenet M., Briennon X., De Kerviler B., Pessaux P., Kohneh-Sharhi N., Lehur P.A., Hamy A., Leborgne J., Le Neel J.C., Mirallie E. Clinical spectrum and surgical approach of adult intussusceptions: a multicentric study. Int. J. Colorectal. Dis., 2006, 21, 834-9.

Brehant O., Pessaux P., Arnaud J.P., Delattre J.F., Meyer C., Baulieux J., Mosnier H. Association Française de Chirurgie. Long-term outcome of laparoscopic J. Gastrointest. Surg., 2006, 10, 439-44.

Goere D., Wagholikar G.D., Pessaux P., Carrère N., Sibert A., Vilgrain V., Sauvanet A., Belhiti J. Utility of staging laparoscopy in subsets of biliary cancers: laparoscopy is a powerful diagnostic tool in patients with intrahepatic and gallbladder carcinoma. Surg. Endosc., 2006, 20, 721-5.

Hennekinne-Mucci S., Tuech J.J., Brehant O., Lermite E., Bergamaschi R., Pessaux P., Arnaud J.P. Emergency subtotal/total colectomy in the management of obstructed left colon carcinoma. Int. J. Colorectal. Dis., 2006, 21, 538-41.

Pessaux P., Arnaud J.P., Delattre J.F., Meyer C., Baulieux J., Mosnier H. Laparoscopic antireflux surgery: five-year results and beyond in 1340 patients. Arch. Surg., 2006, 140, 946-51.

Pessaux P., Kianmanesh R., Regimbeau J.M., Sastre B., Delcenserie R., Sielezneff I., Arnaud J.P., Sauvanet A. Frey procedure in the treatment of chronic pancreatitis: short-term results. Pancreas, 2006, 33, 354-8.

Pessaux P., Lermite E., Blezel E., Msika S., Hay J.M., Flamant Y., Deepak V., Arnaud J.P. French Associations for Surgical Research. Predictive risk score for infection after inguinal hernia repair. Am. J. Surg., 2006, 192, 165-71.

Pessaux P., Lermite E., Brehant O., Tuech J.J., Lorimer G., Arnaud J.P. Repeat hepatectomy for recurrent colorectal liver metastases. J. Surg. Oncol., 2006, 93, 1-7.

Pessaux P., Varma D., Arnaud J.P. Pancreaticoduodenectomy: superior mesenteric artery first approach. J. Gastrointest. Surg., 2006, 10, 607-11.

Reviews/editorials etc.

Barth H., Liang T.J., Baumert T.F. Hepatitis C virus entry: molecular biology and clinical implications. Hepatology, 2006, 44, 527-35.

Zeisel M.B., Baumert T.F. Production of infectious hepatitis C virus in tissue culture: A breakthrough for basic and applied research. J. Hepatol., 2006, 44, 436-9.

Schvoerer E., Thumann C., Soulier E., Royer C., Fafi-Kremer S., Brignon N., Ellero N., Woehl-Jaegle M.L., Meyer C., Wolf P., Jaeck D., Stoll-Keller F. Recurrence of hepatitis C virus (HCV) infection after liver transplantation for HCV-related disease : host factors and viral factors implicated in the occurrence and the severity of HCV recurrence. Pathol. Biol., 2006, 54, 556-560.

Seigneurin J.M., Fafi-Kremer S., Baccard M., Morand P. Diagnostic biologique de l’infection à EBV : actualités en sérologie et en biologie moléculaire. Feuillets de Biologie, 2006, 47, 15-22.

Doffoel M., Ananna A. Palliative treatment of hepatocellular carcinoma. Gastroentérol. Clin. Biol., 2006, 30, 887-90.